The aIgM ADC should remain masked in systemic circulation, but upon reaching the tumor microenvironment, upregulated protease activity promotes cleavage of the substrate linker and subsequent release of the blocking IgM domain (Figure 2B). The gene discussed is CD40LG; the disease is neoplasm.